ArticleMolecular cancer therapeutics2021

M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models.

Michael P Sanderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.